TNXPTonix Pharmaceuticals Holding Corp.同业对比
Tonix Pharmaceuticals Holding Corp. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNXP本股 | $207M#6 | — | 0.9x#5 | 15.8x#4 | 29.8%#3 | 4.6%#6 | -959.1%#5 | -55.8%#9 | -234.8%#4 | — | -55.5%#5 | — |
| SIGA | $224M#3 | — | 1.4x#8 | 2.4x#3 | -31.8%#5 | -60.7%#11 | 25.1%#2 | 14.1%#3 | — | — | -57.1%#7 | 19.2%#1 |
| ZNTL | $225M#2 | — | 1.6x#9 | — | -100.0%#6 | 17.4%#5 | — | -95.4%#11 | — | — | — | — |
| ELDN | $218M#4 | — | 6.6x#13 | — | — | -26.1%#9 | — | -138.2%#13 | — | — | — | — |
| KROS | $213M#5 | — | 0.8x#3 | 0.9x#2 | 6775.0%#1 | 146.4%#3 | 27.7%#1 | 33.2%#1 | — | — | -31.9%#4 | — |
| BRVE | $2.6B#1 | — | — | — | — | — | — | — | — | — | — | — |
| NKTX | $206M#7 | — | 0.8x#4 | — | — | 4.3%#7 | — | -42.0%#7 | — | — | 47.9%#2 | — |
| KRRO | $204M#8 | — | 2.0x#11 | 31.9x#5 | 181.5%#2 | -40.3%#10 | -1906.4%#6 | -113.6%#12 | -155.2%#3 | — | -55.7%#6 | — |
| ANTX | $202M#9 | — | 2.7x#12 | — | — | 31.5%#4 | — | -46.3%#8 | — | — | 316.0%#1 | — |
| PEPG | $200M#10 | — | 1.7x#10 | — | — | 0.4%#8 | — | -75.0%#10 | — | — | — | — |
| ORMP | $194M#11 | 1.1x#1 | 1.0x#6 | 97.1x#6 | — | 573.1%#2 | -754.4%#4 | 0.0%#4 | -4.4%#2 | — | — | — |
| ORGO | $181M#12 | — | 1.2x#7 | 0.3x#1 | 17.0%#4 | 4011.1%#1 | 7.9%#3 | 25.0%#2 | 23.2%#1 | — | — | — |
| NERV | $167M#13 | — | — | — | — | -20492.7%#13 | — | — | — | — | — | — |
| RNA | $163M#14 | — | 0.8x#2 | — | — | — | — | 0.0%#5 | — | — | — | — |
| CNTN | $162M#15 | — | 0.4x#1 | — | — | -194.5%#12 | — | -7.9%#6 | — | — | -29.3%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议